亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

丹皮酚新苷 CAS:100291-86-9

 
 
單價(jià) 面議對(duì)比
詢價(jià) 暫無(wú)
發(fā)貨 四川成都市付款后3天內(nèi)
品牌 鈉鈳鋰
過(guò)期 長(zhǎng)期有效
更新 2021-11-25 12:22
 

成都鈉鈳鋰生物科技有限公司

企業(yè)會(huì)員第5年
資料未認(rèn)證
保證金未繳納
詳細(xì)說(shuō)明

nkl-00212
中文名稱:丹皮酚新苷
英文名稱:Apiopaeonoside
英文別名:1-[2-[(6-O-D-Apio-β-D-furanosyl-β-D-glucopyranosyl)oxy]-4-methoxyphenyl]ethanone; Apiopaeonoside
CAS號(hào):100291-86-9
純度: HPLC≥98%

分子式:C20H28O12
分子量:460.43
沸點(diǎn): 765.9±60.0 °C | Condition
密度: 1.55±0.1 g/cm3 | Condition: Temp: 20 °C
pKa值: 12.75±0.70 | Condition: Most Acidic Temp: 25 °C
規(guī)格: 20mg 50mg 100mg 500mg g級(jí)等應(yīng)客戶需求包裝.
提取來(lái)源:牡丹皮
檢測(cè)條件:色譜柱為Dikma Diamonsil C18色譜柱(250mm×4.6mm,5μm);以**-水(含0.085%磷酸)為流動(dòng)相梯度洗脫;柱溫35℃;體積流量1mL/min;檢測(cè)波長(zhǎng)254nm(0~21.5min),230nm(21.5~45min),254nm(45~60min);進(jìn)樣量20μL。
儲(chǔ)存條件: 2-8°C,避光、干燥、密封

用途: 用于鑒別、含量測(cè)定、藥理實(shí)驗(yàn)、活性篩選等科研、實(shí)驗(yàn)室使用;不得用于注射、食用或其他

供應(yīng)商:成都鈉鈳鋰生物科技有限公司

舉報(bào)收藏 0評(píng)論 0
更多>本企業(yè)其它產(chǎn)品
2”-O-沒(méi)食子酰基金絲桃苷 CAS:53209-27-1 甘草酸 CAS:1405-86-3 甘草酸銨 CAS:53956-04-0 甘草查爾酮A CAS:58749-22-7 甘草查爾酮B CAS:58749-23-8 甘草查爾酮C CAS:144506-14-9 重樓皂苷II CAS:50773-42-7 重樓皂苷III CAS:19057-60-4
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |